Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Human/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-SBF1 (1630-1770) is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
SBF1 |
Gene ID: |
6305 |
Uniprot ID: |
MTMR5_HUMAN |
Immunogen Region: |
1630-1770 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1630-1770 of human SBF1 (NP_002963.2). |
Immunogen Sequence: |
PPYDWELAQGPPEPPEEERS DGGAPQSRRRVVWPCYDSCP RAQPDAISRLLEELQRLETE LGQPAERWKDTWDRVKAAQR LEGRPDGRGTPSSLLVSTAP HHRRSLGVYLQEGPVGSTLS LSLDSDQSSGSTTSGSRQAA R |
Function | Acts as an adapter for the phosphatase MTMR2 to regulate MTMR2 catalytic activity and subcellular location. May function as a guanine nucleotide exchange factor (GEF) activating RAB28. Promotes the exchange of GDP to GTP, converting inactive GDP-bound Rab proteins into their active GTP-bound form. Inhibits myoblast differentiation in vitro and induces oncogenic transformation in fibroblasts. |
Protein Name | Myotubularin-Related Protein 5Inactive Phosphatidylinositol 3-Phosphatase 5Set-Binding Factor 1Sbf1 |
Database Links | Reactome: R-HSA-1483248Reactome: R-HSA-8876198 |
Cellular Localisation | CytoplasmPerinuclear Region |
Alternative Antibody Names | Anti-Myotubularin-Related Protein 5 antibodyAnti-Inactive Phosphatidylinositol 3-Phosphatase 5 antibodyAnti-Set-Binding Factor 1 antibodyAnti-Sbf1 antibodyAnti-SBF1 antibodyAnti-MTMR5 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance